Related Experiment Videos
Rat model for human cryptosporidiosis.
P Brasseur1, D Lemeteil, J J Ballet
1Department of Parasitology, Hôtel Dieu, Centre Hospitalier Universitaire, Rouen, France.
Journal of Clinical Microbiology
|May 1, 1988
Summary
Researchers developed a rodent model for persistent Cryptosporidium infection in immunocompromised individuals. This model aids in screening new therapeutic agents for effective Cryptosporidium treatment.
Area of Science:
- Immunology
- Infectious Diseases
- Parasitology
Background:
- Cryptosporidium infection poses a significant treatment challenge, particularly in immunocompromised patients.
- There is a critical need for effective therapeutic strategies against this parasitic infection.
Purpose of the Study:
- To establish and characterize a rodent model of persistent Cryptosporidium infection.
- To evaluate the utility of this model for screening potential therapeutic agents.
Main Methods:
- Sprague-Dawley rats were immunosuppressed using hydrocortisone acetate injections.
- Rats were fed a low-protein diet and subsequently challenged with Cryptosporidium oocysts.
- Oocyst shedding was monitored daily using carbolfuchsin staining.
Main Results:
- The model successfully induced persistent Cryptosporidium infection lasting over 38 days.
- Oocyst shedding was observed from day 2 to day 9 post-infection.
- Subsequent challenges resulted in reduced oocyst excretion, indicating developing protection.
Conclusions:
- This hydrocortisone acetate-induced rodent model effectively simulates persistent Cryptosporidium infection.
- The model is suitable for the preclinical screening of novel therapeutic agents against Cryptosporidium.
- Further research can utilize this model to identify effective treatments for immunocompromised patients.